124 related articles for article (PubMed ID: 36448643)
1. Enhanced Transdermal Absorption of Hyaluronic Acid via Fusion with Pep-1 and a Hyaluronic Acid Binding Peptide.
Yan LH; Zhang YJ; Hu HJ; Zhang C; Wang Y; Xu XT; Zhang TC; Su R; Luo XG
Macromol Biosci; 2023 Mar; 23(3):e2200173. PubMed ID: 36448643
[TBL] [Abstract][Full Text] [Related]
2. Pep-1 as a novel probe for the in situ detection of hyaluronan.
Zmolik JM; Mummert ME
J Histochem Cytochem; 2005 Jun; 53(6):745-51. PubMed ID: 15928323
[TBL] [Abstract][Full Text] [Related]
3. Topical delivery of hyaluronic acid into skin using SPACE-peptide carriers.
Chen M; Gupta V; Anselmo AC; Muraski JA; Mitragotri S
J Control Release; 2014 Jan; 173():67-74. PubMed ID: 24129342
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronic acid-containing ethosomes as a potential carrier for transdermal drug delivery.
Xie J; Ji Y; Xue W; Ma D; Hu Y
Colloids Surf B Biointerfaces; 2018 Dec; 172():323-329. PubMed ID: 30176512
[TBL] [Abstract][Full Text] [Related]
5. Preparation and in vivo evaluation of cationic elastic liposomes comprising highly skin-permeable growth factors combined with hyaluronic acid for enhanced diabetic wound-healing therapy.
Choi JU; Lee SW; Pangeni R; Byun Y; Yoon IS; Park JW
Acta Biomater; 2017 Jul; 57():197-215. PubMed ID: 28476587
[TBL] [Abstract][Full Text] [Related]
6. Fusion with pep-1, a cell-penetrating peptide, enhances the transmembrane ability of human epidermal growth factor.
Luo XG; Ma DY; Wang Y; Li W; Wang CX; He YY; Gu XC; Li XM; Zhou H; Zhang TC
Biosci Biotechnol Biochem; 2016; 80(3):584-90. PubMed ID: 26442995
[TBL] [Abstract][Full Text] [Related]
7. Enhanced transdermal lymphatic drug delivery of hyaluronic acid modified transfersomes for tumor metastasis therapy.
Kong M; Hou L; Wang J; Feng C; Liu Y; Cheng X; Chen X
Chem Commun (Camb); 2015 Jan; 51(8):1453-6. PubMed ID: 25493296
[TBL] [Abstract][Full Text] [Related]
8. Transdermal delivery of relatively high molecular weight drugs using novel self-dissolving microneedle arrays fabricated from hyaluronic acid and their characteristics and safety after application to the skin.
Liu S; Jin MN; Quan YS; Kamiyama F; Kusamori K; Katsumi H; Sakane T; Yamamoto A
Eur J Pharm Biopharm; 2014 Feb; 86(2):267-76. PubMed ID: 24120887
[TBL] [Abstract][Full Text] [Related]
9. Purification, partial characterization of rat kidney hyaluronic acid binding protein and its localization on the cell surface.
Gupta S; Batchu RB; Datta K
Eur J Cell Biol; 1991 Oct; 56(1):58-67. PubMed ID: 1724753
[TBL] [Abstract][Full Text] [Related]
10. Expression and purification of RHC-EGFP fusion protein and its application in hyaluronic acid assay.
Duan N; Lv W; Zhu L; Zheng W; Hua Z
Prep Biochem Biotechnol; 2017 Mar; 47(3):261-267. PubMed ID: 27536858
[TBL] [Abstract][Full Text] [Related]
11. Hyaluronic acid skin penetration evaluated by tape stripping using ELISA kit assay.
Grégoire S; Man PD; Maudet A; Le Tertre M; Hicham N; Changey F; Gaëlle BS; Tran C; Laurence V
J Pharm Biomed Anal; 2023 Feb; 224():115205. PubMed ID: 36549259
[TBL] [Abstract][Full Text] [Related]
12. A hyaluronic acid binding peptide-polymer system for treating osteoarthritis.
Faust HJ; Sommerfeld SD; Rathod S; Rittenbach A; Ray Banerjee S; Tsui BMW; Pomper M; Amzel ML; Singh A; Elisseeff JH
Biomaterials; 2018 Nov; 183():93-101. PubMed ID: 30149233
[TBL] [Abstract][Full Text] [Related]
13. Physicochemical and biological characterization of pep-1/elastin complexes.
Ahmad Nasrollahi S; Taghibiglou C; Fouladdel S; Dinarvand R; Moosavi Movahedi AA; Azizi E; Farboud ES
Chem Biol Drug Des; 2013 Aug; 82(2):189-95. PubMed ID: 23601371
[TBL] [Abstract][Full Text] [Related]
14. Design of novel BSA/hyaluronic acid nanodispersions for transdermal pharma purposes.
Martins M; Azoia NG; Shimanovich U; Matamá T; Gomes AC; Silva C; Cavaco-Paulo A
Mol Pharm; 2014 May; 11(5):1479-88. PubMed ID: 24649886
[TBL] [Abstract][Full Text] [Related]
15. Targeted delivery of hyaluronic acid to the ocular surface by a polymer-peptide conjugate system for dry eye disease.
Lee D; Lu Q; Sommerfeld SD; Chan A; Menon NG; Schmidt TA; Elisseeff JH; Singh A
Acta Biomater; 2017 Jun; 55():163-171. PubMed ID: 28363785
[TBL] [Abstract][Full Text] [Related]
16. Transdermal transport of collagen and hyaluronic acid using water in oil microemulsion.
Szumała P; Jungnickel C; Kozłowska-Tylingo K; Jacyna B; Cal K
Int J Pharm; 2019 Dec; 572():118738. PubMed ID: 31705977
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronic acid modified nanostructured lipid carriers for transdermal bupivacaine delivery: In vitro and in vivo anesthesia evaluation.
Yue Y; Zhao D; Yin Q
Biomed Pharmacother; 2018 Feb; 98():813-820. PubMed ID: 29571251
[TBL] [Abstract][Full Text] [Related]
18. [Construction of artesunate nanoparticles modified by hyaluronic acid and cell-penetrating peptides and its inhibitory effect on cancer cells in vitro].
Li J; Jin S; Dong XR; Han XF; Wang MY
Zhongguo Zhong Yao Za Zhi; 2018 Sep; 43(18):3668-3675. PubMed ID: 30384531
[TBL] [Abstract][Full Text] [Related]
19. Assay of serum hyaluronic acid in clinical application.
Chichibu K; Matsuura T; Shichijo S; Yokoyama MM
Clin Chim Acta; 1989 May; 181(3):317-23. PubMed ID: 2474393
[TBL] [Abstract][Full Text] [Related]
20. Physicochemical properties of pH-sensitive hydrogels based on hydroxyethyl cellulose-hyaluronic acid and for applications as transdermal delivery systems for skin lesions.
Kwon SS; Kong BJ; Park SN
Eur J Pharm Biopharm; 2015 May; 92():146-54. PubMed ID: 25753198
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
